To Invest US$300mn
The Incheon Free Economic Zone (IFEZ) Authority announced on Feb. 14 that Sartorius Korea Operations broke ground for production and research facilities in Songdo International City.
Sartorius Korea Operations is a company set up by Sartorius AG, an international pharmaceutical and laboratory equipment supplier based in Germany.
The company received a building permit last month and began the construction work at the Songdo High-Tech Industrial Cluster B. It plans to complete the facilities by the second half of 2025.
The company will invest US$300 million to build biopharmaceutical raw materials manufacturing and research facilities in Songdo. It signed a land purchase contract with Incheon City and the IFEZ Authority in October of last year.
The facility will produce disposable bags, cell culture media and pharmaceutical filters among others. It will become a global export base for Sartorius AG. In addition, it will promote R&D and education projects in biopharmaceutical processing, transfer its technologies to Korean companies, and stimulate the growth of related industries.
“We will provide our maximum support so that Songdo becomes a global hub not only in biopharmaceutical production but in the supply of raw materials,” said Kim Jin-yong, head of the IFEZ Authority.